Tech Company Financing Transactions
Visikol Funding Round
Visikol secured a financing round on 1/24/2018. Backers included private investors.
Transaction Overview
Company Name
Announced On
1/24/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
private investors (Alan Weiss)
private investors (Brian Mulhall)
Proceeds Purpose
The company intends to use the funds to develop bio-imaging services for drug discovery such as 3D In Vitro cell culture assays as well as expand the its commercial operations.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
295 US Hwy. 22 E 10
Whitehouse Station, NJ 08889
USA
Whitehouse Station, NJ 08889
USA
Phone
Website
Email Address
Overview
Tom Villani invented Visikol in a botanical microscopy class where chloral hydrate was used. After learning of the difficulties the instructor went through to obtain the chloral hydrate -- a highly regulated narcotic with a long history of abuse -- he knew there had to be a better way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Johnson
Chief Scientific Officer
Thomas Villani
VP - Operations
Brian Mulhall
Browse more venture capital transactions:
Prev: 1/24/2018: Springbuk venture capital transaction
Next: 1/24/2018: Knightscope venture capital transaction
Share this article
News on VC Transactions
We record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs